We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current IKNA market cap is 60.28M. The company's latest EPS is USD -1.0202 and P/E is -1.22.
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -18.23M | -15.82M | -12.41M | -12.52M | -10.79M |
| Net Income | -16.15M | -13.73M | -10.23M | -9.12M | -8.62M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 9.19M | 30.99M | 15.62M | 9.16M | 0 |
| Operating Income | -44.52M | -34.14M | -70.9M | -75.42M | -58.97M |
| Net Income | -44.26M | -34.12M | -68.77M | -68.17M | -49.23M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 172.78M | 157.49M | 148.99M | 141.51M | 130.84M |
| Total Liabilities | 17.44M | 14.63M | 14.76M | 15.58M | 12.59M |
| Total Equity | 155.35M | 142.86M | 134.23M | 125.93M | 118.25M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 168.4M | 247.88M | 172.26M | 192.09M | 141.51M |
| Total Liabilities | 63.47M | 40M | 25.29M | 22.34M | 15.58M |
| Total Equity | -101.05M | 207.88M | 146.97M | 169.76M | 125.93M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -18.3M | -30.81M | -39.74M | -46M | -10.56M |
| Investing | -48.74M | -44.82M | -35.37M | -34.9M | 7.93M |
| Financing | N/A | N/A | N/A | N/A | N/A |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -37.83M | -60.25M | -74.11M | -79.74M | -46M |
| Investing | 2.92M | -1.76M | -99.28M | 64.14M | -34.9M |
| Financing | 116.18M | 131.74M | 1.1M | 75.98M | N/A |
| Market Cap | 60.28M |
| Price to Earnings Ratio | -1.22 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 1.52 |
| Price to Book Ratio | 0.48 |
| Dividend Yield | - |
| Shares Outstanding | 48.26M |
| Average Volume (1 week) | 894.8k |
| Average Volume (1 Month) | 273.72k |
| 52 Week Change | -26.09% |
| 52 Week High | 1.94 |
| 52 Week Low | 0.9707 |
| Spread (Intraday) | 0.01 (0.8%) |
| Company Name | Ikena Oncology Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.ikenaoncology.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
